Special notice
RRPV Solicitation Summary: COVID-19 Monoclonal Antibody Therapeutics for Treatment
RPP-24-03-Treatment
Office of Assistant Secretary for Preparedness and Response, Barda - Aspr / Daappo / Barda DCMA. Research and Development in Biotechnology (except Nanobiotechnology).
Response deadline
April 8, 2024 at 1:00 PM EDT
Closed 893 days ago. Posted February 21, 2024. Scheduled to archive April 23, 2024.
Description
As published on SAM.gov.
This solicitation summary is to notify all potential offerors of a Request for Project Proposals (RPP) issued through the Rapid Response Partnership Vehicle (RRPV) Consortium on behalf of Biomedical Advanced Research and Development Authority (BARDA) entitled "COVID-19 Monoclonal Antibody Therapeutics for Treatment". The full RPP and information on joining the consortium can be accessed through the RRPV website www.rrpv.org. Thank you for your interest in this requirement.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
February 21, 2024
Special notice
Due April 8, 2024 at 1:00 PM EDT. SAM.gov, notice 6adaaeb52894454f9ac4e5909dd1f6c7
Points of contact
- Rebecca Harmonrebecca.harmon@ati.org
Also open from this buyer
- Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & ResponseSolicitationNAICS 541714Washington, DC75A50126R00001_RFP_NPIVS_27Closes in 63 daysNov 20
- BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)SolicitationNAICS 541714DRIVeEZBAA22100SOL00003Closes in 395 daysOct 18, 2027